Actineer Inc.

https://www.actineer.com

Actineer™ Inc. is a joint venture company between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM) dedicated to advancing Ac-225 technologies, quickly securing supply, and producing industrial-scale quantities of this valuable, rare medical radioisotope for the treatment of cancer. Founded in October 2023, Actineer™ Inc. together with its strong supply chain collaborators will progress Ac-225 development, production and processing technologies. It has established short-term production capabilities that is expected to lead to significantly boosting international supplies, while working long-term towards the construction of a new Actinium Production Facility (APF) in Canada. The joint venture’s mission is to fulfil the unmet global manufacturing and production needs of this coveted radioisotope with significant potential in the fight against cancer. *

	Start	2023-10-01 established jv
	Group	ITM Isotope Technologies Munich SE
	Industry	RADIOPHARMACEUTICAL (RPT)
	Person	Oliverio, Joseph (ITM Isotope Technologies Munich 202501– CEO of Actineer before Ionetix + Imagin Molecular + Positron)

	Street	286 Plant Road
	City	KOJ 1J0 Chalk River, ON
		Address record changed: 2025-01-17

Basic data	Employees	n. a.

		* Document for »About Section«: ITM Isotope Technologies Munich SE. (1/16/25). "Press Release: Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO". Chalk River, ON.

		Record changed: 2025-01-19